Netherlands Oncology Clinical Trials Market Analysis

Netherlands Oncology Clinical Trials Market Analysis

$ 3999

Netherlands oncology clinical trials Market is projected to grow from $32.9 Mn in 2022 to $52.4 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The market will be driven by the country's strong healthcare system, experienced clinical researchers, and a supportive government. The market is segmented by phase, by study design & by indication. Some of the major players include Roche Holding AG, Pfizer Inc & Kiadis Pharma.

ID: IN10NLCT006 CATEGORY: Clinical Trials GEOGRAPHY: Netherlands AUTHOR: Vidhi Upadhyay

Buy Now

Netherlands Oncology Clinical Trials Market Executive Summary

Netherlands oncology clinical trials Market is projected to grow from $32.9 Mn in 2022 to $52.4 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The most prevalent malignancies among women in the Netherlands are lung, colon, and breast cancer. In 2022, 124.109 people were diagnosed with cancer: 65.591 males and 58.518 women. In the Netherlands, more than 850.000 people have cancer or have survived cancer. The Netherlands was one of the first nations to establish a cancer institute: the Netherlands Cancer Institute (NKI). The NKI, which was founded in 1913, is today one of the world's greatest comprehensive cancer centers.

Many oncology clinical trials are now underway in the Netherlands. These studies are intended to put innovative cancer treatments, therapies, and diagnostic technologies to the test. These studies are taking place in many medical facilities and hospitals around the Netherlands, including the Erasmus Medical Center, the University Medical Center Utrecht, and the Netherlands Cancer Institute. The Netherlands has a well-developed healthcare system and a solid research infrastructure, making it a suitable site for clinical trials. The nation also boasts a highly educated populace, with many people eager to take part in clinical trials to enhance medical knowledge and improve cancer treatment choices.

netherlands oncology clinical trials market anlaysis

Market Dynamics

Market Growth Drivers

Oncode Institute, one of the biggest strategic public-private collaborations in the Netherlands, brings together 800+ exceptional cancer researchers from 12 universities, academic hospitals, and research organizations. The Netherlands is leading in oncology not only in Europe, but across the globe, owing to innovative prevention, diagnostics, and therapies nurtured in a connected and collaborative environment. According to recent research, the Netherlands is the second-best country in the world for cancer treatment and the best in Europe. With over 500 public-private collaborations, a key location for R&D cooperation, and accessibility for Europeans seeking treatment – as well as solid logistics to simplify manufacture and distribution worldwide - the country is well-positioned. The country's strong healthcare system experienced clinical researchers, and the supportive government provides a solid foundation for growth in this area.

Market Restraints

There are certain limitations to oncology clinical trials in the Netherlands. One of the most significant challenges is the stringent standards regulating clinical studies. The regulatory procedure may be time-consuming and complicated, and failing to comply can result in fines. This may be difficult for certain firms, especially those unfamiliar with the Dutch regulatory structure. Competition is another challenge confronting oncology clinical trials in the Netherlands. Since nations compete to recruit clinical trials, the Netherlands may face competition from other countries that provide comparable benefits. Additionally, although the Netherlands government funds research and development, financing for clinical trials may be difficult to come by. Many organisations need substantial financial resources to perform clinical trials, and obtaining financing may be difficult.

Competitive Landscape

Key Players

  • Roche Holding AG
  • Pfizer Inc.
  • Novartis International AG
  • Merck & Co., Inc.
  • AstraZeneca plc
  • Eli Lilly and Company
  • Sanofi S.A.
  • Bristol Myers Squibb Company
  • Kiadis Pharma (NLD)
  • ISA Pharmaceuticals BV (NLD)

Notable Insights

  1. February 2023, The Netherlands Cancer Institute is doing research on a novel form of mesothelioma therapy. For individuals with BAP1 genetic alterations, researchers are investigating a unique combination of current drugs.
  2. September 2022, the new treatment, according to the researchers at the Netherlands Cancer Institute, utilizes a patient's own immune cells to attack cancer, and its therapy is comparable to another form of treatment that has shown to be very successful for blood malignancies, known as CAR-T therapy.
  3. April 2022, The Netherlands is investing 325 million euros ($351 million) in the development of preclinical cancer drugs. The Netherlands National Growth Fund intended to use the funds to establish specific competencies that would aid biotech in the development of cancer prospects.

Healthcare Policies and Regulatory Landscape

The Netherlands maintains two registries related to clinical trials. The Central Committee on Research Involving Human Subjects (CCMO) is a national registry that requires clinical trial data performed in the Netherlands or by a Dutch researcher to be posted. The summary findings must be submitted to the CCMO registry. Another registry that allows protocol registration is the National Trial Registry (NTR). It is a main registry recognized by the World Health Organization (WHO). NTR will have a new website starting on December 15, 2022. The NTR is administered by the CCMO, and once fully operational, the CCMO will reapply to the WHO for registration recognition.

The European Union Clinical Trial Information System (EU CTIS) became operational on January 31, 2022, and the Clinical Trials Regulation (Regulation (EU) No 536/2014) is currently in effect. EU CTIS will assist with protocol registration as well as results reporting for clinical trials performed in the EU/EEA.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Clinical Trials Regulation in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation

6. Methodology and Scope

Oncology Clinical Trials Market Segmentation

By Phase (Revenue, USD Billion):

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Study Design Outlook (Revenue, USD Billion):

  • Epilepsy
  • Parkinson's Disease (PD)
  • Huntington's Disease
  • Stroke
  • Traumatic Brain Injury (TBI)
  • Amyotrophic Lateral Sclerosis (ALS)
  • Muscle regeneration
  • Others

By Indication Outlook  (Revenue, USD Billion):

  • Interventional
  • Observational
  • Expanded Access

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 22 December 2023
Updated by: Ritu Baliya

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter